Table V.
Summary of the patients’ follow-up parameters
| Authors | Patient follow-up/Measured indicators |
|---|---|
| Lewis et al ., 2020 | TACO - Surgery - Recovery |
| Miller et al ., 2018 | HR - Blood Pressure - pH - Lactate - Hb - PLT count |
| Bassett et al ., 2016 | pH - BE - Hb. 30 days follow-up: survival + transfusion reaction/blood borne pathogens transfer - OR time - time to transfer |
| Strandenes et al ., 2015 | Not reported |
| Garcia Hejl et al ., 2015 | Sample for immunoassays infectious agents: HTLV, HIV, HBV, Syphilis + Nucleic Acid Testing: HIV, HCV, HBV |
| Hrezo and Clark, 2003 | Blood count - PT/PTT - Hb - HR - BP - sO2 . Sample for future serologic testing. 48 h follow-up - Surgery |
| Gaspary et al ., 2020 | Sample back for pre-screening to add donor to register |
| Hakre et al ., 2013 | Transfusion associated adverse events. TTD’s: HTLV - WBC - Temperature |
| Malsby et al ., 2005 | Pulse - BP - Surgery. Follow-up 4 weeks |
| Liu et al ., 2014 | Temperature - HR - Respiratory rate - BP - Hb - PT- INR - PTT - PLT count - Calcium level - Surgery - Acute lung injury - Respiratory distresses |
| Gaddy et al ., 2021 | sO2 - BP - HR - Respiration - Pulse - Glasgow score - Surgery |
| Song et al ., 2021 | Survival - Surgery |
TACO: transfusion-associated circulatory overload; HR: heart rate; Hb: hemoglobin; PLT: platelets; BE: base excess; OR: operating room; HTLV: human T lymphotropic virus; HIV: human immunodeficiency virus; HBV: hepatitis B virus; PT/PTT: prothrombin time/partial thromboplastin time; BP: blood pressure; sO2: oxygen saturation; TTD: transfusion transmitted disease; WBC: white blood cells; INR: international normalized ratio.